Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex

Abstract

Host factors that silence provirus transcription in CD4+ memory T cells help HIV-1 escape eradication by the host immune system and by antiviral drugs1. These same factors, however, must be overcome for HIV-1 to propagate. Here we show that Vpx and Vpr encoded by diverse primate immunodeficiency viruses activate provirus transcription. Vpx and Vpr are adaptor proteins for the DCAF1-CUL4A/B E3 ubiquitin ligase that degrade SAMHD1 and increase reverse transcription2,3,4. Nonetheless, Vpx and Vpr have effects on reporter gene expression that are not explained by SAMHD1 degradation5,6,7,8. A screen for factors that mimic these effects identified the human silencing hub (HUSH) complex, FAM208A (TASOR/RAP140), MPHOSPH8 (MPP8), PPHLN1 (PERIPHILIN) and MORC29,10,11,12,13. Vpx associated with the HUSH complex and decreased steady-state level of these proteins in a DCAF1/CUL4A/B/proteasome-dependent manner14,15. Replication kinetics of HIV-1 and SIVMAC was accelerated to a similar extent by vpx or FAM208A knockdown. Finally, vpx increased steady-state levels of LINE-1 ORF1p, as previously described for FAM208A disruption11. These results demonstrate that the HUSH complex represses primate immunodeficiency virus transcription, and that, to counteract this restriction, viral Vpx or Vpr proteins degrade the HUSH complex.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Diverse primate immunodeficiency virus vpx and vpr orthologues activate provirus transcription, whether delivered before, during or after reporter provirus integration.
Fig. 2: Vpx activates provirus transcription by degrading HUSH complex components.
Fig. 3: The HIV-1 LTR is activated by Vpx or disruption of FAM208A.
Fig. 4: Vpx counteracts FAM208A restriction of exogenous HIV-1 and SIVMAC239 infection and of endogenous LINE-1.

Similar content being viewed by others

Data availability

All data needed to evaluate the conclusions in the paper are present in the paper or in the supplementary table. The plasmids described in Supplementary Table 1, along with their complete nucleotide sequences, are available at https://www.addgene.org/Jeremy_Luban/.

References

  1. Siliciano, J. D. et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9, 727–728 (2003).

    Article  CAS  Google Scholar 

  2. Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658–661 (2011).

    Article  CAS  Google Scholar 

  3. Laguette, N. et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654–657 (2011).

    Article  CAS  Google Scholar 

  4. Lim, E. S. et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe. 11, 194–204 (2012).

    Article  CAS  Google Scholar 

  5. Pertel, T., Reinhard, C. & Luban, J. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology 8, 49 (2011).

    Article  CAS  Google Scholar 

  6. Reinhard, C., Bottinelli, D., Kim, B. & Luban, J. Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration. Retrovirology 11, 12 (2014).

    Article  Google Scholar 

  7. Goh, W. C. et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat. Med. 4, 65–71 (1998).

    Article  CAS  Google Scholar 

  8. Miller, C. M. et al. Virion-associated Vpr alleviates a postintegration block to HIV-1 infection of dendritic cells. J. Virol. 91, e00051-17 (2017).

    Article  Google Scholar 

  9. Tchasovnikarova, I. A. et al. GENE SILENCING. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells. Science 348, 1481–1485 (2015).

    Article  CAS  Google Scholar 

  10. Tchasovnikarova, I. A. et al. Hyperactivation of HUSH complex function by Charcot–Marie–Tooth disease mutation in MORC2. Nat. Genet. 49, 1035–1044 (2017).

    Article  CAS  Google Scholar 

  11. Liu, N. et al. Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators. Nature 553, 228–232 (2018).

    Article  CAS  Google Scholar 

  12. Liu, L. et al. A whole genome screen for HIV restriction factors. Retrovirology 8, 94 (2011).

    Article  CAS  Google Scholar 

  13. Blewitt, M. E. et al. An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. Proc. Natl Acad. Sci. USA 102, 7629–7634 (2005).

    Article  CAS  Google Scholar 

  14. Le Rouzic, E. et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6, 182–188 (2007).

    Article  Google Scholar 

  15. Srivastava, S. et al. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 4, e1000059 (2008).

    Article  Google Scholar 

  16. Neagu, M. R. et al. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J. Clin. Invest. 119, 3035–3047 (2009).

    Article  CAS  Google Scholar 

  17. Re, F., Braaten, D., Franke, E. K. & Luban, J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69, 6859–6864 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Chang, F., Re, F., Sebastian, S., Sazer, S. & Luban, J. HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes. Mol. Biol. Cell 15, 1793–1801 (2004).

    Article  CAS  Google Scholar 

  19. He, J. et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69, 6705–6711 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. McCarthy, K. R. & Johnson, W. E. Plastic proteins and monkey blocks: How lentiviruses evolved to replicate in the presence of primate restriction factors. PLoS Pathog. 10, e1004017 (2014).

    Article  Google Scholar 

  21. Fregoso, O. I. et al. Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog. 9, e1003496 (2013).

    Article  CAS  Google Scholar 

  22. Weinberg, M. S. & Morris, K. V. Transcriptional gene silencing in humans. Nucleic Acids Res. 44, 6505–6517 (2016).

    Article  Google Scholar 

  23. Chéné, I. et al. Suv39H1 and HP1γ are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J. 26, 424–435 (2007).

    Article  Google Scholar 

  24. Wolf, D. & Goff, S. P. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131, 46–57 (2007).

    Article  CAS  Google Scholar 

  25. Peterlin, B. M. et al. Hili inhibits HIV replication in activated T cells. J. Virol. 91, e00237-17 (2017).

    Article  Google Scholar 

  26. Wang, G. Z. & Goff, S. P. Transcriptional silencing of moloney murine leukemia virus in human embryonic carcinoma cells. J. Virol. 91, e02075-16 (2017).

    Article  Google Scholar 

  27. Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361–365 (2011).

    Article  CAS  Google Scholar 

  28. Robbez-Masson, L. et al. The HUSH complex cooperates with TRIM28 to repress young retrotransposons and new genes. Genome Res. 28, 836–845 (2018).

    Article  CAS  Google Scholar 

  29. Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (2003).

    Article  CAS  Google Scholar 

  30. Chen, H.-C., Martinez, J. P., Zorita, E., Meyerhans, A. & Filion, G. J. Position effects influence HIV latency reversal. Nat. Struct. Mol. Biol. 24, 47–54 (2017).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to dedicate these experiments to the memory of Jan Svoboda (1934–2017), whose demonstration that cells may carry Rous sarcoma virus genetic information in the absence of any infectious virus production provided support to the proviral hypothesis. We thank L. Cavacini for antibodies and N. Landau for SIV plasmids. The following reagents were obtained through the AIDS Reagent Program, Division of AIDS, NIAID, NIH: J-Lat Tat-GFPCells (A1) from Dr. Eric Verdin and SIVmac239 SpX and SIVmac239 SpX ΔVpx from Dr. Ronald C. Desrosiers. This research was supported by National Institutes of Health (USA) grants nos. R01AI111809, RO1AI117839 and DP1DA034990 to J.L.

Author information

Authors and Affiliations

Authors

Contributions

L.Y. and J.L. designed the experiments. L.Y. performed the experiments with assistance from M.H.G., K.K., S.L.G., S.M., A.D. and W.E.D. L.Y. and J.L. analysed the experimental data. All authors contributed to the writing of the manuscript.

Corresponding author

Correspondence to Jeremy Luban.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Supplementary Information

Supplementary Figures 1–5 and Supplementary Table 1.

Reporting Summary

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yurkovetskiy, L., Guney, M.H., Kim, K. et al. Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex. Nat Microbiol 3, 1354–1361 (2018). https://doi.org/10.1038/s41564-018-0256-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41564-018-0256-x

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing